Anti-tumour necrosis factor α therapy - Does it increase the risk of thyroid disease or protect against its development?
CONCLUSIONS: The real impact of anti-TNF-α therapy on the development of AITD remains an open question. The available studies concern the adult population; there are no data regarding this problem in children. Due to the increasing use of anti-TNF-α therapy also in the paediatric population, it seems reasonable to evaluate this subject in this group of patients.
PMID: 32462852 [PubMed - as supplied by publisher]
Source: Pediatric Endocrinology, Diabetes, and Metabolism - Category: Endocrinology Authors: Furtak A, Wedrychowicz A, Starzyk J Tags: Pediatr Endocrinol Diabetes Metab Source Type: research
More News: Allergy & Immunology | Ankylosing Spondylitis | Arthritis | Autoimmune Disease | Child Development | Children | Diabetes | Endocrinology | Inflammatory Bowel Disease | Pediatrics | Psoriasis | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Study | Thyroid